KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Times Interest Earned (2017 - 2025)

Historic Times Interest Earned for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Q3 2025 value amounting to -$18.1.

  • Biomarin Pharmaceutical's Times Interest Earned fell 14718.0% to -$18.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $57.53, marking a year-over-year increase of 16601.96%. This contributed to the annual value of $38.23 for FY2024, which is 25672.76% up from last year.
  • Biomarin Pharmaceutical's Times Interest Earned amounted to -$18.1 in Q3 2025, which was down 14718.0% from $103.35 recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Times Interest Earned ranged from a high of $103.35 in Q2 2025 and a low of -$18.1 during Q3 2025
  • For the 5-year period, Biomarin Pharmaceutical's Times Interest Earned averaged around $20.57, with its median value being $10.15 (2022).
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Times Interest Earned surged by 166370.63% in 2023, and later tumbled by 14718.0% in 2025.
  • Over the past 5 years, Biomarin Pharmaceutical's Times Interest Earned (Quarter) stood at -$17.13 in 2021, then surged by 78.93% to -$3.61 in 2022, then surged by 223.94% to $4.47 in 2023, then skyrocketed by 1300.13% to $62.63 in 2024, then plummeted by 128.91% to -$18.1 in 2025.
  • Its last three reported values are -$18.1 in Q3 2025, $103.35 for Q2 2025, and $78.2 during Q1 2025.